The latest oncology news listed by date, covering all clinical focus areas, tumour types and more
Researchers have discovered a previously unknown mechanism that explains how bacteria can drive treatment resistance…
The ESMO Congress 2025 has seen pivotal studies unveiling compelling evidence that a new class of…
Results from a trial presented at ESMO 205 have shown that a targeted therapy combination improved…
A multicenter Phase II clinical trial has demonstrated significant tumour shrinkage and disease control in patients…
Patients with oestrogen-receptor-positive HER-2-negative advanced breast cancer showed significantly improved progression-free survival when treated with…
A multicentre study led by London Health Sciences Centre Research Institute (LHSCRI), Lawson Research Institute…
Treatment with osimertinib plus a platinum–pemetrexed chemotherapy combination resulted in statistically significant and clinically meaningful…
Glioblastoma (GBM), a malignant tumour originating from glial cells, is the most common primary tumour…
A drug that harnesses the immune system to attack cancer cells has proved successful in…
Understanding the interaction between immune cells and cancer cells has significant implications for cancer immunotherapies,…